

Cover Story
COVID-19 & CancerFreeGuest Editorial
Cancer patients and survivors should not get COVID-19. A three-time cancer survivor should definitely not get COVID. But I did. And it was not good. Here is my story and the lessons I learned that might be of value to others.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Jan. 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The future of oncology: Early-career scientists need mentorship and a new academic model
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights













